BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34806617)

  • 1. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
    Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
    Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance Between Anticholinergic Burden Scales.
    Naples JG; Marcum ZA; Perera S; Gray SL; Newman AB; Simonsick EM; Yaffe K; Shorr RI; Hanlon JT;
    J Am Geriatr Soc; 2015 Oct; 63(10):2120-4. PubMed ID: 26480974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
    Hsu WH; Wen YW; Chen LK; Hsiao FY
    Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
    Sheu JJ; Tsai MT; Erickson SR; Wu CH
    Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
    Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
    J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
    Lee EK; Lee YJ
    Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
    Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
    Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergics May Carry Significant Cognitive and Gait Burden in Parkinson's Disease.
    Rajan R; Saini A; Verma B; Choudhary N; Gupta A; Vishnu VY; Bhatia R; Singh MB; Srivastava AK; Srivastava MVP
    Mov Disord Clin Pract; 2020 Oct; 7(7):803-809. PubMed ID: 33043076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study.
    Amoros-Reboredo P; Soy D; Hernandez-Hernandez M; Lens S; Mestres C
    Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32466526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
    Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
    Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
    Yarnall AJ; Lawson RA; Duncan GW; Breen DP; Khoo TK; Brooks D; Barker RA; Taylor JP; Burn DJ
    J Parkinsons Dis; 2015; 5(4):743-7. PubMed ID: 26444094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Anticholinergic Burden in Parkinson's Disease After Deep Brain Stimulation.
    Jiao J; Brumbach BH; Hantke N; Wilhelmi M; Bonilla C; Safarpour D
    Neuromodulation; 2024 Apr; 27(3):538-543. PubMed ID: 38085189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
    Novella A; Elli C; Ianes A; Pasina L
    Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.